Close Menu

NextGen Group

The American Society for Mass Spectrometry has named University of Wisconsin-Madison researcher Josh Coon winner of its Klaus Biemann Medal.

NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

This story originally ran on Feb. 2.
Protein biomarker firm NextGen Group said this week that it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of €800,000 ($1.05 million).

Citing lower than expected sales in its biomarker and testing business, protein biomarker firm NextGen Group said this week it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of £650,000 ($1.04 million).

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.